Codiak BioSciences, Inc. Proceeds from Issuance Initial Public Offering
Codiak BioSciences, Inc. reported Proceeds from Issuance Initial Public Offering of $74.40 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-11-19
- 2020-09-30: Proceeds from Issuance Initial Public Offering 9 month $74.40M.
| Period end | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|
| 2020-09-30 | $74.40M 10-Q · filed 2020-11-19 |